window.amJwVideos = window.amJwVideos || ; window.amJwVideos.push(‘jw-hook-W1diUqVW’); window.amJwAdthriveVideos = window.amJwAdthriveVideos || ; window.amJwAdthriveVideos.push(‘jw-adthrive-hook-W1diUqVW’);
Former Food and Drug Administration chief Dr. Scott Gottlieb said Monday he faults the federal government for delays that were likely to prevent Merck’s Covid-19 pill from reaching the market until 2022.
Merck on Monday submitted an application to the FDA for an Emergency Use Authorization enabling distribution of its Covid-19 drug, molnupiravir, to treat patients who have the virus. However, Gottlieb said that regardless of his former agency’s decision, it was unlikely the pill would reach a wide swath of the market before 2022.
“The … lament